Interferons  	Interferons  	 JJ	O
beta  	beta  	 NNS	B-NP
have  	have  	 VBP	O
vasoconstrictive  	vasoconstrictive  	 VBN	O
and  	and  	 CC	O
procoagulant  	procoagulant  	 JJ	B-NP
effects 	effects 	 NNS	I-NP
:  	:  	 :	O
a  	a  	 DT	O
woman  	woman  	 NN	O
who  	who  	 WP	O
developed  	developed  	 VBD	O
livedo  	livedo  	 JJ	B-NP
reticularis  	reticularis  	 NN	I-NP
and  	and  	 CC	O
Raynaud  	Raynaud  	 NNP	B-NP
phenomenon  	phenomenon  	 NN	I-NP
in  	in  	 IN	O
association  	association  	 NN	O
with  	with  	 IN	O
interferon  	interferon  	 JJ	B-NP
beta  	beta  	 NN	I-NP
treatment  	treatment  	 NN	I-NP
for  	for  	 IN	O
multiple  	multiple  	 JJ	O
sclerosis  	sclerosis  	 NNS	O
A  	A  	 DT	O
31-year-old  	31-year-old  	 JJ	O
woman  	woman  	 NN	O
with  	with  	 IN	O
MS  	MS  	 NNP	B-NP
developed  	developed  	 VBD	O
livedo  	livedo  	 JJ	B-NP
reticularis  	reticularis  	 NN	I-NP
and  	and  	 CC	O
secondary  	secondary  	 JJ	B-NP
Raynaud  	Raynaud  	 JJ	I-NP
phenomenon  	phenomenon  	 NN	I-NP
2.5  	2.5  	 CD	O
years  	years  	 NNS	O
after  	after  	 IN	O
introduction  	introduction  	 NN	B-NP
of  	of  	 IN	I-NP
interferon  	interferon  	 CD	I-NP
beta-1b 	beta-1b 	 CD	I-NP
.  	.  	 .	O
The  	The  	 DT	O
symptoms  	symptoms  	 NNS	B-NP
disappeared  	disappeared  	 VBD	O
after  	after  	 IN	O
withdrawal  	withdrawal  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
drug 	drug 	 NN	O
.  	.  	 .	O
Livedo  	Livedo  	 JJ	B-NP
reticularis  	reticularis  	 NN	I-NP
and  	and  	 CC	O
Raynaud  	Raynaud  	 NNP	B-NP
phenomenon  	phenomenon  	 NN	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
pulmonary  	pulmonary  	 JJ	B-NP
arterial  	arterial  	 JJ	I-NP
hypertension 	hypertension 	 NN	I-NP
,  	,  	 ,	O
venous  	venous  	 FW	B-NP
sinus  	sinus  	 FW	I-NP
thrombosis 	thrombosis 	 FW	I-NP
,  	,  	 ,	O
pulmonary  	pulmonary  	 JJ	B-NP
embolism  	embolism  	 NN	I-NP
and  	and  	 CC	O
renal  	renal  	 JJ	B-NP
thrombotic  	thrombotic  	 JJ	I-NP
microangiopathy  	microangiopathy  	 NNS	I-NP
have  	have  	 VBP	O
all  	all  	 RB	O
been  	been  	 VBN	O
described  	described  	 VBN	O
in  	in  	 IN	O
association  	association  	 NN	O
with  	with  	 IN	O
interferon  	interferon  	 JJ	B-NP
beta  	beta  	 NN	I-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
complications  	complications  	 NNS	B-NP
strongly  	strongly  	 RB	O
suggest  	suggest  	 VB	O
that  	that  	 DT	O
type  	type  	 NN	O
I  	I  	 PRP	O
interferons  	interferons  	 RB	O
have  	have  	 VB	O
vasoconstrictive  	vasoconstrictive  	 NNS	B-NP
and  	and  	 CC	O
procoagulant  	procoagulant  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
with  	with  	 IN	O
potentially  	potentially  	 RB	O
serious  	serious  	 JJ	B-NP
systemic  	systemic  	 JJ	I-NP
complications 	complications 	 NNS	I-NP
.  	.  	 .	O
